eon Corporation announced that, through Zeon Ventures Inc. its subsidiary that manages corporate venture capital (CVC) activities, it has invested in Kanvas Biosciences, (“Kanvas”), a Princeton, New Jerseybased spatial biology company developing therapeutics that leverage the gut microbiome—a community of microorganisms that coexist in the human intestinal tract. Through this investment, Zeon will advance the exploration of new business opportunities related to this area.
Tokyo, Japan – Zeon Corporation announced that, through Zeon Ventures Inc. its subsidiary that manages
corporate venture capital (CVC) activities, it has invested in Kanvas Biosciences, (“Kanvas”), a Princeton, New Jerseybased spatial biology company… [1621 chars]
Source: RubberWorld | Published: 2026-06-19T04:58:00Z
Credit: RubberWorld
